These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer. Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350 [TBL] [Abstract][Full Text] [Related]
5. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours. Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer. Lipponen PK J Cancer Res Clin Oncol; 1993; 119(5):295-300. PubMed ID: 7680044 [TBL] [Abstract][Full Text] [Related]
7. Grading of superficial bladder cancer by quantitative mitotic frequency analysis. Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H J Urol; 1993 Jan; 149(1):36-41. PubMed ID: 8417213 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335 [TBL] [Abstract][Full Text] [Related]
10. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Lipponen PK; Eskelinen MJ Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364 [TBL] [Abstract][Full Text] [Related]
11. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder. Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464 [TBL] [Abstract][Full Text] [Related]
12. The changing importance of prognostic factors in bladder cancer during a long-term follow-up. Lipponen P Eur J Cancer; 1993; 29A(9):1261-5. PubMed ID: 8343264 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer. Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203 [TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma. Lin CT; Tung CL; Tsai YS; Shen CH; Jou YC; Yu MT; Wu SF Urol Oncol; 2012 Sep; 30(5):680-7. PubMed ID: 21420334 [TBL] [Abstract][Full Text] [Related]
15. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma. Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index. Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho P; Haapasalo H J Cancer Res Clin Oncol; 1992; 118(8):615-20. PubMed ID: 1517282 [TBL] [Abstract][Full Text] [Related]
18. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer. Lipponen PK Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668 [TBL] [Abstract][Full Text] [Related]
19. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]